Is the research you value a waste of money? by Walters, Corbin et al.
Is the Research you Value a Waste of Money?  
College of Osteopathic Medicine 
Corbin Walters OMS I, Angela Clifton OMS I, Ian Fladie OMS I, Chase Meyer OMS III, Trevor Torgerson OMS I, Matt Vassar Ph.D.
Oklahoma State College of Osteopathic Medicine Chase Meyer OS III, Trevor Torgerson OMS I, Corbin Walters OMS I, Ian Fladie OMS I, Angela Clifton OMS I, Matt Vassar, PhD
Objectives and Hypothesis
Eighty-five percent of health research may be wasted, 
resulting in $170 billion annually in wasteful research 
spending worldwide.1 Given the increased use of 
randomized trials and their influence on medicine, one 
method to combat research waste is to conduct RCTs 
only when a systematic review (SR) suggests more 
data are needed or when no previous systematic 
reviews are identified. We hypothesize SRs would be 
rarely cited as justification for conducting RCTs.
METHODS
We analysed RCTs published between 2016 and 
2018 in New England Journal of Medicine, Lancet, 
and Journal of the American Medical Association. 
We performed duplicate and independent data 
extraction to ensure the accuracy and validity of our 
data. For each trial, we extracted whether SRs were 
cited as justification for conducting the clinical trial.
Summary
Very few clinical trials cite systematic reviews as the 
basis for undertaking the trial. We believe trialists 
should be required to present relevant systematic 
reviews to an ethics or peer review committee 
demonstrating an unmet need prior to initiating a 
trial. Eliminating research waste is both a scientific 
and ethical responsibility.
RESULTS
SRs Cited in RCTs
Our search retrieved 665 records, of which 628 were included. Overall, 
706 SR’s were cited in these 628 RCTs; of which, 318 were referenced 
in the introduction, 82 in the methods, and 306 in the discussion. 49 
SRs were cited verbatim as justification for conducting the trial. RCTs 
published in Lancet were more likely to cite a SR as justification for 
conducting the trial.
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SRs used as Justification for Conducting RCT
Research Articles Analysed
Funding source n (%)
Government 268 (43)
Industry 263 (42)
Non-Profit 55 (9)
Hospital / University 24 (4)
Combined Non-Profit and Industry 12 (2)
Not Reported 5 (0)
Self-Funded 1 (0)
Year Published
2017 307 (49)
2016 294 (47)
2018 27 (4)
Type of Intervention
Drug 385 (61)
Other 109 (17)
Procedure 105 (17)
Medical Device 29 (5)
Type of Trial
Parallel Groups 595 (95)
Cluster Randomized 22 (3)
Crossover 11 (2)
Average Participants
Range: 6-
1194147; 5943
Efficacy of Results
Positive 377 (60)
Negative 251 (40)
Citations in High Impact Journals
Top Three High Impact Journals:
